Depending on the degree of restriction, in hepatic impairment the maximum plasma focus of nortilidine is decreased than in hepatic healthy subjects and also the fifty percent-life is prolonged. In circumstances of intense hepatic impairment, therapy is questionable. Use or redistribution of any DrugBank content or data needs a license https://richardk912fgh5.wikicommunications.com/user